Earnings call: QIAGEN posts mixed Q1 results, reaffirms 2024 outlook

QIAGEN N.V. (NYSE: QGEN) reported a 5% decline in net sales for the first quarter of 2024, totaling $462 million at constant exchange rates, compared to the same period last year. Despite this, the company's Diagnostic Solutions product gro
Read more...